Glenmark Life Sciences Limited
Bookbuilding IPO · NSE, BSE
- Price band
- ₹695-₹720
- Lot size
- 20 shares
- Issue amount
- ₹1,514 cr
- Total subscription
- 0×
- Opens
- 27 Jul 2021
- Closes
- 29 Jul 2021
- Allotment
- 3 Aug 2021
- Listing
- 6 Aug 2021
Offer at a glance
Issue overview
- Issue size
- 2,10,22,222 shares
- Face value
- ₹2 per share
- Minimum investment
- ₹13,900
- Fresh issue
- ₹1,060 cr
- Offer for sale
- ₹454 cr
- Registrar
- Kfin Technologies Limited
- Listing exchange
- NSE, BSE
- Maximum investment
- ₹14,400
- Issue type
- Bookbuilding IPO
- Shares before issue
- 10,78,04,950
- Shares after issue
- 12,25,27,172
Lot sizes
| Category | Lots | Shares | Amount |
|---|---|---|---|
| RETAIL | 1 | 20 | ₹14,400 |
| sHNI | 13 | 280 | ₹2,01,600 |
| bHNI | 70 | 1,400 | ₹10,08,000 |
Share reservation
Subscription & GMP
Subscription by category
Subscription figures are awaiting publication.
GMP history
Financial performance
Company financials
In Lakhs · Reported periods may include interim results.
Company information
Company profile
Incorporated in 2011, Glenmark Life Sciences is a leading manufacturer of active pharmaceutical ingredients (APIs), developing and supplying high-quality products used in treatments for cardiovascular, central nervous system, pain management, diabetes, gastrointestinal disorders, anti-infectives, and other therapeutic areas. The company serves customers in India and exports its products to several international markets including Europe, North America, Latin America, and Japan. It operates four manufacturing facilities located at Ankleshwar and Dahej in Gujarat, and Mohol and Kurkumbh in Maharashtra, with a total annual installed capacity of 725.8 KL as of December 31, 2020.
Strengths
- Leading API Manufacturer: Specializes in APIs for chronic therapies like CVS, CNS, diabetes, and pain management.
- Global Exports: Supplies products across Europe, Latin America, North America, Japan, and other regions.
- Strong Global Relationships: Works closely with leading generic pharmaceutical companies worldwide.
- Strong Financials: Proven track record of consistent financial performance.
- Quality & R&D Focus: High-quality manufacturing supported by robust R&D infrastructure.
Promoters
Glenmark Pharmaceuticals Limited
Registrar & documents
Lead manager
Bofa Securities India Limited, Bob Capital Markets Limited, Dam Capital Advisors Limited, Goldman Sachs (India) Securities Private Limited, Kotak Mahindra Capital Company Limited, SBI Capital Markets Limited
Registrar & contacts
Kfin Technologies Limited
[email protected]Official registrar portal ↗Check allotment status on registrar →Registered office
Plot No. 170-172, Chandramouli Industrial Estate, Mohol Bazarpeth, Solapur 413 213,
+91 2189 234456
[email protected]Company website ↗Frequently Asked Questions
What is Glenmark Life Sciences IPO GMP today?
As of today, Glenmark Life Sciences IPO Grey Market Premium (GMP) is reported at +₹82 per share. Based on the upper price band of ₹720, the estimated listing price is ₹802 (+11.4% expected listing gain). Please note that GMP is an unofficial market estimate for sentiment tracking and does not guarantee the actual listing price.
What is the lot size and minimum investment for Glenmark Life Sciences IPO?
The minimum bid lot size for Glenmark Life Sciences IPO is 20 shares. At the cut-off price of ₹720 per share, retail investors need a minimum application amount of ₹14,400 per lot. Retail applicants can apply for a maximum of 13 lots (up to ₹2,00,000).
When will Glenmark Life Sciences IPO allotment status be announced?
The allotment status for Glenmark Life Sciences IPO is scheduled to be finalized on 3 Aug 2021. If you applied for the IPO, you can verify whether shares have been allocated to your Demat account through Kfin Technologies Limited's official portal or via BSE/NSE allotment portals.
How can I check Glenmark Life Sciences IPO allotment status online by PAN?
To check Glenmark Life Sciences IPO allotment status: 1) Visit the registrar portal (Kfin Technologies Limited) or the BSE IPO allotment page. 2) Select 'Glenmark Life Sciences Limited' from the company dropdown. 3) Choose 'PAN' as your identification mode and enter your 10-digit Permanent Account Number. 4) Click 'Search' to view your allotted share quantity and application status.
Explore More IPO Analysis & Live Tools
Compare the price band and required investment with company financials and official offer documents. Grey market premium (GMP) figures are indicative market estimates collected from primary market brokers and do not establish the official listing price.